Every 8-K that Aemetis, Inc. (DE) (AMTX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow AMTX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMTX filings page.
Aemetis reported significantly improved Q2 2026 results, with revenue of $62.7 million, including $8.6 million of Section 45Z production tax credits, up 20% year over year. Gross profit reached $13.5 million and operating income was $5.8 million, reversing losses in the prior-year quarter.
Performance was driven by higher volumes and prices in the California Ethanol segment, lower delivered corn costs, and 38% growth in Dairy Renewable Natural Gas volumes, supported by seven approved LCFS provisional pathways. Adjusted EBITDA turned positive at $9.7 million, while the India biodiesel business operated at low nameplate utilization.
Despite operating improvements, Aemetis posted a Q2 net loss of $9.4 million and ended June 30, 2026 with $1.0 million in cash, about $415.0 million of current liabilities, and a stockholders' deficit of roughly $322.1 million. The company is pursuing multiple financing initiatives, including Keyes plant refinancing, Dairy RNG funding, and a potential IPO of its India subsidiary.
Aemetis, Inc. held its Annual Meeting of Stockholders on May 20, 2026. Stockholders voted on the election of one director and the ratification of the company’s independent auditor.
For the board election, Lydia I. Beebe received 18,110,640 votes for, 627,847 withheld, and 19,501,347 broker non-votes. She was elected as a Class II director to serve until the 2029 annual meeting and until a successor is elected and qualified.
Stockholders also voted on the ratification of the company’s independent registered public accounting firm. KPMG LLP received 37,777,860 votes for, 85,378 against, and 376,596 abstentions, with no broker non-votes, and was ratified as auditor for the fiscal year ending December 31, 2026.
Aemetis, Inc. reported first quarter 2026 results showing strong top-line growth but continued losses. Revenue rose 27% year over year to $54.6 million, driven by contributions from California Ethanol, Dairy Renewable Natural Gas (RNG), and India Biodiesel.
The company generated $2.8 million of gross profit, reversing a gross loss in the prior-year quarter, helped by Section 45Z Production Tax Credits and improved Dairy RNG performance. Operating loss narrowed to $6.3 million, and net loss improved to $21.7 million, while Adjusted EBITDA improved to negative $1.3 million from negative $10.7 million.
Dairy RNG volumes increased 55% to 110,000 MMBtu, and India Biodiesel revenue reached $10.5 million with resumed tender orders. The company ended the quarter with $4.8 million in cash and continues to invest in low-carbon projects and multi-track financing initiatives, including work toward an IPO of its India subsidiary.
Aemetis, Inc. has approved the engagement of KPMG LLP as its independent registered public accounting firm starting with the quarter ending March 31, 2026 and the fiscal year ending December 31, 2026, subject to an engagement letter. The Audit Committee also dismissed RSM US LLP as auditor effective after completion of the December 31, 2025 audit and related non-audit services, ending a relationship that began in 2012. RSM’s reports on the 2024 and 2025 financial statements contained no adverse or qualified opinions, but each included an explanatory paragraph about Aemetis’ ability to continue as a going concern. The company reports no disagreements with RSM and notes previously disclosed material weaknesses in internal control over financial reporting as of December 31, 2024, which were discussed with RSM and about which KPMG may inquire.
Aemetis, Inc. reported 2025 results showing strong growth in its dairy renewable natural gas platform but continued overall losses and a weaker top line. Full-year revenues were $197.6 million plus $10.4 million of production tax credits, down from $267.6 million of revenue in 2024. Net loss narrowed to $77.0 million from $87.5 million, helped by cost reductions and tax credit sales.
The dairy RNG segment produced about 405,000 MMBtu in 2025 and increased fourth-quarter production by 61% year over year, generating $9.6 million of gross profit versus $5.4 million in 2024. The California ethanol plant delivered $158.3 million of 2025 revenue and credits, while India biodiesel revenue fell to $29.7 million amid tender delays.
Fourth-quarter 2025 revenue and production tax credits totaled $53.7 million, up from $47.0 million a year earlier, and gross profit improved to $7.7 million from a $2.0 million gross loss. Cash increased to $4.9 million at year-end 2025, but Aemetis carried a stockholders’ deficit of $306.8 million and current liabilities of $371.3 million against total assets of $259.8 million.
Aemetis, Inc. amended its Certificate of Incorporation to increase authorized capital stock to 205,000,000 shares, including a rise in authorized common stock from 80,000,000 to 140,000,000 shares, following stockholder approval at a special meeting.
Stockholders did not approve a reduction in authorized preferred stock from 65,000,000 to 5,000,000 shares, but did approve a discretionary adjournment proposal. Aemetis also updated the official description of its capital stock and filed a legal opinion covering the legality of up to $210,000,000 of common stock that may be sold from time to time under its existing at‑the‑market offering program.
Aemetis, Inc. reported that its subsidiary Aemetis Biogas LLC entered into an Eleventh Waiver and Amendment to its Series A Preferred Unit Purchase Agreement with Protair-X Technologies Inc. and Third Eye Capital Corporation. The amendment extends the deadline to redeem all outstanding Series A Preferred Units from December 31, 2025 to April 30, 2026 and sets the aggregate redemption price at $114.7 million, which reflects prior payments and a $2 million fee for this amendment. If the units are not redeemed by the new date, Aemetis Biogas LLC would instead enter into a credit agreement with Protair-X and Third Eye Capital, effective May 1, 2026, maturing May 1, 2027, with interest at the greater of 16.0% or the prime rate plus 10.0%, guaranteed by Aemetis, Inc. and several subsidiaries and secured by their assets.
Aemetis, Inc. approved several governance and capital actions. The board’s committee authorized an annual $350,000 guarantee fee to McAfee Capital LLC, wholly owned by Chairman and CEO Eric A. McAfee, for personal guarantees supporting certain credit facilities and debt obligations, continuing the company’s historical practice.
The committee also granted discretionary cash bonuses to key executives, including $200,000 to Mr. McAfee and $125,000 each to three executive vice presidents, with another executive vice president receiving $50,000. Separately, the board authorized a share repurchase program allowing the company to buy back up to $80 million of common stock over time, with purchases made at management’s discretion and no set end date. The company is also holding a special stockholder meeting to vote on charter amendments to change authorized common and preferred share levels.
Aemetis (AMTX) reported that it issued an earnings press release for the three and nine months ended September 30, 2025. The release is furnished as Exhibit 99.1 to a Form 8-K under Item 2.02 and Item 7.01, and is posted on the company’s website. The Form 8-K and Exhibit 99.1 are deemed “furnished” rather than “filed” under the Exchange Act and are not incorporated by reference into any registration statement.
Aemetis, Inc. disclosed that subsidiary Aemetis Biogas LLC (ABGL) executed a Tenth Waiver and Amendment to its Series A Preferred Unit Purchase Agreement with Protair-X Technologies Inc. and Third Eye Capital, effective August 31, 2025. The amendment extends ABGL’s deadline to redeem all outstanding Series A Preferred Units from August 31, 2025 to December 31, 2025 and sets the aggregate redemption price at $118.8 million, which includes a $2 million amendment fee.
If ABGL does not redeem by the new deadline, it will enter a Credit Agreement in substantially the attached form, effective January 1, 2026, maturing September 1, 2026, with interest at the greater of 16.0% or the prime rate plus 10.0%. The agreement would require guarantees from Aemetis, Inc. and certain subsidiaries and grant security interests in the assets of ABGL and the guarantors. Protair-X currently owns 100% of ABGL’s Series A Preferred Units.